Advertisement

Eyelid Malposition: Unique Scenarios in Cancer Patients

  • Aaron Savar
  • Bita Esmaeli
Chapter
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)

Abstract

Eyelid malposition in cancer patients encompasses a variety of conditions, including ectropion, entropion, ptosis, eyelid retraction, and eyelid malposition due to periorbital edema. Ectropion is by far the most commonly encountered form of eyelid malposition in cancer patients. In some situations, the eyelid abnormality is the presenting sign of an underlying malignancy, but most often, it is the result of therapeutic interventions for cancer.

Keywords

Imatinib Mesylate Lower Eyelid Plexiform Neurofibroma Periorbital Edema Eyelid Retraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Golio D, De Martelaere S, Anderson J, et al. Outcomes of periocular reconstruction for facial nerve paralysis in cancer patients. Plast Reconstr Surg 2007;119:1233–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Methvin AB, Gausas RE. Newly recognized ocular side effects of erlotinib. Ophthal Plast Reconstr Surg 2007;23:63–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Garibaldi DC, Adler RA. Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab. Ophthal Plast Reconstr Surg 2007;23:62–3.PubMedCrossRefGoogle Scholar
  4. 4.
    Straus DJ, Mausolf FA, Ellerby RA, et al. Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Pediatr Oncol 1977;3:15–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Hurwitz BS. Cicatricial ectropion: a complication of systemic fluorouracil. Arch Ophthalmol 1993;111:1608–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Cook BE Jr, Bartley GB, Pittelkow MR. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma. Ophthalmology 1999;106:1339–44.CrossRefGoogle Scholar
  7. 7.
    Beyer TL, Dryden RM. Basal cell carcinoma masquerading as ectropion. Arch Ophthalmol 1988;106:170–1.PubMedCrossRefGoogle Scholar
  8. 8.
    Mahoney NR, Liu GT, Menacker SJ, et al. Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol 2006;142:651–9.PubMedCrossRefGoogle Scholar
  9. 9.
    van Oosterom AT, Judson I, Verweij J, et al. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 2001;358:1421–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Esmaeli B, Prieto VG, Butler CE, et al. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 2002;95:881–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Larson JS, Bergstrom LK, Cameron JD, et al. Severe periorbital edema secondary to imatinib mesylate for chronic myelogenous leukemia. Arch Ophthalmol 2007;125:985–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Section of Ophthalmology, Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations